Burning Rock Biotech (BNR) Price & Analysis

Q: What was Burning Rock Biotech Ltd.’s price range in the past 12 months?

Burning Rock Biotech Ltd. lowest stock price was $2.18 and its highest was $23.59 in the past 12 months.

Q: What is Burning Rock Biotech Ltd.’s market cap?

Burning Rock Biotech Ltd.’s market cap is $251.83M.

Q: When is Burning Rock Biotech Ltd.’s upcoming earnings report date?

Burning Rock Biotech Ltd.’s upcoming earnings report date is Mar 31, 2026 which is in 96 days.

Q: How were Burning Rock Biotech Ltd.’s earnings last quarter?

Burning Rock Biotech Ltd. released its earnings results on Nov 20, 2025. The company reported -$0.217 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.217.

Q: Is Burning Rock Biotech Ltd. overvalued?

According to Wall Street analysts Burning Rock Biotech Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does Burning Rock Biotech Ltd. pay dividends?

Burning Rock Biotech Ltd. does not currently pay dividends.

Q: What is Burning Rock Biotech Ltd.’s EPS estimate?

Burning Rock Biotech Ltd.’s EPS estimate for its next earnings report is not yet available.

Q: How many shares outstanding does Burning Rock Biotech Ltd. have?

Burning Rock Biotech Ltd. has 9,034,111 shares outstanding.

Q: What happened to Burning Rock Biotech Ltd.’s price movement after its last earnings report?

Burning Rock Biotech Ltd. reported an EPS of -$0.217 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.119%.

Q: Which hedge fund is a major shareholder of Burning Rock Biotech Ltd.?

Currently, no hedge funds are holding shares in BNR

Compare

87 Followers

BNR Stock Chart & Stats

$19.48

<$0.01(0.06%)

At close: Jan 08 4:00 PM EST

$19.48

<$0.01(0.06%)

Day’s Range― - ―

52-Week Range$2.18 - $23.59

Previous CloseN/A

Volume1.44K

Average Volume (3M)22.64K

Market Cap

$251.83M

Enterprise Value-$24.01M

Total Cash (Recent Filing)$463.99M

Total Debt (Recent Filing)$33.18M

Price to Earnings (P/E)―

Beta1.76

Next Earnings

Mar 31, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.22

Shares Outstanding9,034,111

10 Day Avg. Volume13,298

30 Day Avg. Volume22,645

Financial Highlights & Ratios

PEG Ratio<0.01

Price to Book (P/B)0.09

Price to Sales (P/S)0.10

P/FCF Ratio-0.52

Enterprise Value/Market Cap-0.10

Enterprise Value/Revenue-0.04

Enterprise Value/Gross Profit-0.06

Enterprise Value/Ebitda0.38

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Burning Rock Biotech News

Burning Rock Biotech Shareholders Approve All Resolutions at 2025 AGM

Burning Rock Biotech ( ($BNR) ) has provided an announcement. On December 23, 2025, Burning Rock Biotech announced...

2d ago

BNR

Burning Rock Biotech Schedules 2025 AGM for December 23

An update from Burning Rock Biotech ( ($BNR) ) is now available. Burning Rock Biotech Limited announced that...

24d ago

BNR

Burning Rock Biotech’s Q3 2025 Financial Highlights

Burning Rock Biotech Ltd. ( ($BNR) ) has released its Q3 earnings. Here is a breakdown of the...

1M ago

BNR

Burning Rock Biotech Announces Q3 2025 Financial Results with Revenue Growth

An announcement from Burning Rock Biotech ( ($BNR) ) is now available. Burning Rock Biotech reported its financial...

1M ago

BNR

Burning Rock announces OncoGuide OncoScreen Plus CDx System approval in Japan

Riken Genesis and Burning Rock Biotech (BNR) announced that the OncoGuide OncoScreen Plus CDx System based on OncoScreen...

3M ago

AZN

BNR

Burning Rock Biotech Reports Q2 2025 Financial Results

Burning Rock Biotech Ltd. ( ($BNR) ) has released its Q2 earnings. Here is a breakdown of the...

4M ago

BNR

Burning Rock Biotech Reports Improved Q2 2025 Financial Results

An announcement from Burning Rock Biotech ( ($BNR) ) is now available. Burning Rock Biotech reported its financial...

4M ago

BNR

Burning Rock Biotech Ltd (ADR) trading resumes

09:57 EDT Burning Rock Biotech (BNR) Ltd (ADR) trading resumes Published first on TheFly – the ultimate source...

5M ago

BNR

Burning Rock Biotech Ltd (ADR) trading halted, volatility trading pause

09:52 EDT Burning Rock Biotech (BNR) Ltd (ADR) trading halted, volatility trading pause Published first on TheFly –...

5M ago

BNR

Burning Rock Biotech Reports Q1 2025 Financial Results

Burning Rock Biotech Ltd. ( ($BNR) ) has released its Q1 earnings. Here is a breakdown of the...

7M ago

BNR

Burning Rock Biotech Reports Q1 2025 Financial Results and Advances in Oncology Research

An announcement from Burning Rock Biotech ( ($BNR) ) is now available. Burning Rock Biotech reported its financial...

7M ago

BNR

Burning Rock Biotech Reports 2024 Financial Results

Burning Rock Biotech Ltd. ( ($BNR) ) has released its Q4 earnings. Here is a breakdown of the...

9M ago

BNR

Burning Rock Biotech reports Q4 EPS (RMB 0.79) vs. (RMB 1.58) last year

Reports Q4 revenue RMB 126.02M vs. RMB 121.09M last year. Cash, cash equivalents, restricted cash were RMB 522.2M....

9M ago

BNR

Burning Rock Biotech Ltd (ADR) trading resumes

09:50 EST Burning Rock Biotech (BNR) Ltd (ADR) trading resumes Published first on TheFly – the ultimate source...

10M ago

BNR

BNR FAQ

What was Burning Rock Biotech Ltd.’s price range in the past 12 months?

Burning Rock Biotech Ltd. lowest stock price was $2.18 and its highest was $23.59 in the past 12 months.

What is Burning Rock Biotech Ltd.’s market cap?

Burning Rock Biotech Ltd.’s market cap is $251.83M.

When is Burning Rock Biotech Ltd.’s upcoming earnings report date?

Burning Rock Biotech Ltd.’s upcoming earnings report date is Mar 31, 2026 which is in 96 days.

How were Burning Rock Biotech Ltd.’s earnings last quarter?

Burning Rock Biotech Ltd. released its earnings results on Nov 20, 2025. The company reported -$0.217 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.217.

Is Burning Rock Biotech Ltd. overvalued?

According to Wall Street analysts Burning Rock Biotech Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Burning Rock Biotech Ltd. pay dividends?

Burning Rock Biotech Ltd. does not currently pay dividends.

What is Burning Rock Biotech Ltd.’s EPS estimate?

Burning Rock Biotech Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Burning Rock Biotech Ltd. have?

Burning Rock Biotech Ltd. has 9,034,111 shares outstanding.

What happened to Burning Rock Biotech Ltd.’s price movement after its last earnings report?

Burning Rock Biotech Ltd. reported an EPS of -$0.217 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.119%.

Which hedge fund is a major shareholder of Burning Rock Biotech Ltd.?

Currently, no hedge funds are holding shares in BNR

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Burning Rock Biotech Stock Smart Score

Neutral

Fundamentals

Return on Equity

-19.87%

Trailing 12-Months

Asset Growth

-18.26%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Burning Rock Biotech Ltd.

Burning Rock Biotech (BNR) is a leading precision oncology company based in China that focuses on the development of innovative genomic testing solutions for cancer patients. The company specializes in the research and development of advanced diagnostic products, including next-generation sequencing (NGS) assays that enable personalized treatment strategies. BNR operates primarily in the biotechnology sector, offering services that facilitate early detection and targeted therapies for various forms of cancer, thereby improving patient outcomes.